Literature DB >> 824067

Allergens of mammalian origin V. Properties of extracts derived from the domestic cat.

J L Ohman, F C Lowell, K J Bloch, S Kendall.   

Abstract

Eight commercial cat dander extracts and two pelt extracts derived from mongrel and Siamese cats were compared. Cat allergn 1 and cat albumin were measured by radial immunodiffusion. Allergenic activity was evaluated by prick test and a modified radioallergosorbent test. In the latter, the dilution of each extract that produced 50% inhibition of binding of IgE antibodies to insolubilized cat allergen 1 (RAST 1) and insolubilized cat serum (RAST 2) was determind. The total non-dialysable solid content of the extracts did not correlate with any other parameter. Cat allergen 1 content determined by radial immunodiffusion correlated with average prick test results in ten cat-sensitive subjects and with RAST 1 activity. Cat albumin content correlated weakly with RAST 2 activity but not with any other measure of allergenic activity. Absorption of each extract with the gamma-globulin fraction of rabbit antiserum to cat allergen 1 significantly reduced prick test reactivity and RAST 1 activity, but not RAST 2 activity. These results indicate that cat allergen 1 is an important allergen in cat dander extracts and its measurement may be used to standardize the allergenic activity of such extracts.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824067     DOI: 10.1111/j.1365-2222.1976.tb01926.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  3 in total

Review 1.  Standardized allergenic extracts derived from mammals.

Authors:  J L Ohman; B Sundin
Journal:  Clin Rev Allergy       Date:  1987-02

Review 2.  Cat allergens.

Authors:  H Baer
Journal:  Surv Immunol Res       Date:  1982

Review 3.  Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis.

Authors:  Shao-Heng He; Hui-Yun Zhang; Xiao-Ning Zeng; Dong Chen; Ping-Chang Yang
Journal:  Acta Pharmacol Sin       Date:  2013-08-26       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.